India has 29 states with at least 720 districts comprising of approximately 6 lakh villages, and over 8200 cities and towns. Indian postal department has allotted a unique postal code of pin code ...

Last week, Sana Biotechnology, a once-mysterious and still-buzzy biotech startup, released clinical trial results showing that it had managed to implant insulin-producing cells in the arm muscle ...

At Boston Medical Center, Dr. Archana Asundi, who directs the center’s infectious disease clinical research unit, said many of her patients living with HIV who are experiencing accelerated ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

We introduce Sana, a text-to-image framework that can efficiently generate images up to 4096 × 4096 resolution. Sana can synthesize high-resolution, high-quality images with strong text-image ...

Starring, Natasha Rajeshwari, Sana Asundi, Lucky Saini. Watch it on, Voovi. Cast: Natasha Rajeshwari, Sana Asundi, Lucky Saini Mol Ki Bahu is a web series that begins with a seemingly happy family.

Sana Biotechnology, Inc. stock will be surging today after the company showed it can safely administer its allogeneic cell therapy for diabetes to a patient with no immunosuppression. Engineered ...

Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with type 1 diabetes, sending the company’s share price up by about 200%.

Sana Biotechnology (SANA) and eBay (EBAY) are two of the stocks rallying this morning despite the market's losses. Sana is soaring nearly 250%, while eBay is climbing a much more modest 12%.

Sana’s HIP technology is designed to overcome the immunologic rejection of allogeneic cells. In type 1 diabetes, it also evades the autoimmune rejection of pancreatic beta cells. UP421 cells ...

https://www.tipranks.com/news/the-fly/fortress-biotech-announces-first-patient-dosed-in-phase-2-trial-of-triplex BofA lowered the firm’s price target on Sana ...